Description
From Kalorama Information and Science and Medicine Group (publishers of Instrument Business Outlook) comes a new publication focusing on the business of clinical testing.
In Vitro Diagnostics Business Outlook offers the following:
- Market Sizing and Forecasting of IVD Market Segments in Every Issue
- Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
- Industry Watch – Developments with COVID-19 and Other Testing
- M&A, Distribution, Partnerships Tracked and Charted
- New Product Introductions and Company Announcements
- Company Profiling and Quarterly Results Summaries
- Regional Market Coverage
With issues 2x a month, this newsletter dedicated to In Vitro Diagnostics is the best way to keep up in this rapidly-developing and well financed field.
Finding markets with higher growth than the average is critical
Convenient and Cost-Effective Seat-Based Pricing: Pricing depends on the number of users. Subscriptions can be as low as $2,200 annually for a limited one-person (single user) subscription. If more than one person will be reading, you can unlock access to other members of your organization. It’s easy to do: team subscription prices are as little as $4,995 annually for up to five readers.
| License | 1 Year (24 Issues) |
2 Years (save 10%) |
3 Years (save 15%) |
|---|---|---|---|
| Single User | $2,200 | $3,960 | $5,610 |
| Team (5 Users) |
$4,995 | $8,991 | $12,737.25 |
| Group (15 Users) |
$6,995 | $12,591 | $17,837.25 |
| Department (50 Users) |
$11,995 | $21,591 | $30,587.25 |
| Corporate (250 Users) |
$19,995 | $35,991 | $50,987.25 |
| Enterprise (Unlimited Users) |
$30,000 | Inquire | Inquire |
